Renoprotection of angiotensin receptor blockers: Beyond blood pressure lowering

Toshio Miyata, Charles van Ypersele de Strihou

Research output: Contribution to journalEditorialpeer-review

14 Citations (Scopus)


To summarize, the discovery of unexpected benefits of ARBs and ACEIs, unrelated to BP lowering, suggests a new paradigm to understand the genesis and progression of renal disease in diabetic and perhaps other patients. Novel therapeutic strategies will, hopefully, ensue.

Original languageEnglish
Pages (from-to)846-849
Number of pages4
JournalNephrology Dialysis Transplantation
Issue number4
Publication statusPublished - 2006 Apr


  • Advanced glycation end products
  • Blood pressure
  • Chronic hypoxia
  • Diabetic nephropathy
  • Oxidative stress
  • PAI-1
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Fingerprint Dive into the research topics of 'Renoprotection of angiotensin receptor blockers: Beyond blood pressure lowering'. Together they form a unique fingerprint.

Cite this